Fibrocell Science, Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 13 rows in 2018. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2018-06-27: Reporting owner Buckley Sean D.; Form 3; Security Option to Purchase Common Stock; Transaction Holding.
- 2018-06-27: Reporting owner Buckley Sean D.; Form 3; Security Option to Purchase Common Stock; Transaction Holding.
- 2018-06-27: Reporting owner Buckley Sean D.; Form 3; Security Option to Purchase Common Stock; Transaction Holding.
- 2018-06-27: Reporting owner Buckley Sean D.; Form 3; Security Option to Purchase Common Stock; Transaction Holding.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2018-06-27 holding as of filing | Buckley Sean D. Officer (See Remarks) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $232.50 exercise price | 2018-06-27 | ||
| 2018-06-27 holding as of filing | Buckley Sean D. Officer (See Remarks) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $82.35 exercise price | 2018-06-27 | ||
| 2018-06-27 holding as of filing | Buckley Sean D. Officer (See Remarks) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $63.60 exercise price | 2018-06-27 | ||
| 2018-06-27 holding as of filing | Buckley Sean D. Officer (See Remarks) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $11.25 exercise price | 2018-06-27 | ||
| 2018-06-27 holding as of filing | Buckley Sean D. Officer (See Remarks) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $11.25 exercise price | 2018-06-27 | ||
| 2018-06-27 holding as of filing | Buckley Sean D. Officer (See Remarks) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $3.45 exercise price | 2018-06-27 | ||
| 2018-06-19 | Moore Kelvin Director | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,000 6,000 owned after | $2.36 exercise price | 2018-06-21 | |
| 2018-06-19 | Mazur Marc Director | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,000 6,000 owned after | $2.36 exercise price | 2018-06-21 | |
| 2018-06-19 | St.Clare Christine Director | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,000 6,000 owned after | $2.36 exercise price | 2018-06-21 | |
| 2018-06-19 | Swirsky Douglas J Director | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,000 6,000 owned after | $2.36 exercise price | 2018-06-21 | |
| 2018-06-19 | Smith Marcus E. Director | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,000 6,000 owned after | $2.36 exercise price | 2018-06-21 | |
| 2018-06-19 | Kirk Julian P. Director | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,000 6,000 owned after | $2.36 exercise price | 2018-06-21 | |
| 2018-01-25 | Maslowski John Michael Director, Officer (CEO) | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +100,000 100,000 owned after | $0.69 exercise price | 2018-01-29 |